HomeXSPRAY • STO
add
XSpray Pharma AB (publ)
Previous close
kr 31.70
Day range
kr 30.50 - kr 31.75
Year range
kr 28.65 - kr 90.61
Market cap
944.70M SEK
Avg Volume
21.07K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 79.30M | 189.25% |
Net income | -81.97M | -50.41% |
Net profit margin | — | — |
Earnings per share | -2.36 | — |
EBITDA | -77.64M | -210.97% |
Effective tax rate | 0.04% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 208.24M | 25.21% |
Total assets | 796.34M | 4.06% |
Total liabilities | 173.25M | 141.12% |
Total equity | 623.10M | — |
Shares outstanding | 37.14M | — |
Price to book | 1.89 | — |
Return on assets | -27.08% | — |
Return on capital | -28.93% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -81.97M | -50.41% |
Cash from operations | -61.60M | -88.81% |
Cash from investing | -19.20M | 7.37% |
Cash from financing | 214.02M | 144.64% |
Net change in cash | 133.48M | 294.63% |
Free cash flow | -71.85M | -590.28% |
About
Founded
2003
Website
Employees
25
